News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
274,014 Results
Type
Article (14723)
Company Profile (282)
Press Release (259009)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (81053)
Career Advice (221)
Deals (13606)
Drug Delivery (36)
Drug Development (50838)
Employer Resources (33)
FDA (5797)
Job Trends (5257)
News (146911)
Policy (10409)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (6)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (979)
Accelerated approval (2)
Adcomms (12)
Allergies (53)
Alliances (22183)
ALS (65)
Alzheimer's disease (873)
Antibody-drug conjugate (ADC) (100)
Approvals (5823)
Artificial intelligence (135)
Autoimmune disease (18)
Automation (5)
Bankruptcy (109)
Best Places to Work (4663)
BIOSECURE Act (6)
Biosimilars (43)
Biotechnology (233)
Bladder cancer (58)
Brain cancer (20)
Breast cancer (156)
Cancer (1503)
Cardiovascular disease (118)
Career advice (190)
Career pathing (3)
CAR-T (119)
Cell therapy (334)
Cervical cancer (9)
Clinical research (41345)
Collaboration (548)
Compensation (261)
Complete response letters (13)
COVID-19 (1077)
CRISPR (42)
C-suite (165)
Cystic fibrosis (76)
Data (1540)
Denatured (11)
Depression (30)
Diabetes (140)
Diagnostics (1461)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (10)
Drug discovery (88)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (90)
Earnings (30426)
Editorial (18)
Employer branding (5)
Employer resources (31)
Events (49335)
Executive appointments (465)
FDA (6513)
Featured Employer (31)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (504)
Gene editing (97)
Generative AI (13)
Gene therapy (254)
GLP-1 (375)
Government (1197)
Grass and pollen (2)
Guidances (22)
Healthcare (6848)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (92)
Indications (20)
Infectious disease (1143)
Inflammatory bowel disease (116)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (67)
Interviews (29)
IPO (7443)
IRA (11)
Job creations (881)
Job search strategy (168)
Kidney cancer (7)
Labor market (5)
Layoffs (210)
Leadership (6)
Legal (1449)
Liver cancer (34)
Lung cancer (210)
Lymphoma (105)
Machine learning (3)
Management (7)
Manufacturing (141)
MASH (53)
Medical device (2768)
Medtech (2769)
Mergers & acquisitions (6505)
Metabolic disorders (393)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (68)
Neuropsychiatric disorders (25)
Neuroscience (1284)
NextGen: Class of 2025 (2082)
Non-profit (924)
Northern California (1725)
Now hiring (21)
Obesity (195)
Opinion (111)
Ovarian cancer (63)
Pain (43)
Pancreatic cancer (56)
Parkinson's disease (122)
Partnered (8)
Patents (130)
Patient recruitment (78)
Peanut (36)
People (25975)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14581)
Phase II (19241)
Phase III (12176)
Pipeline (820)
Policy (47)
Postmarket research (872)
Preclinical (6170)
Press Release (30)
Prostate cancer (63)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (295)
Real estate (1454)
Recruiting (12)
Regulatory (8870)
Reports (15)
Research institute (972)
Resumes & cover letters (33)
Rett syndrome (5)
RNA editing (5)
RSV (10)
Schizophrenia (60)
Series A (99)
Series B (63)
Service/supplier (1)
Sickle cell disease (41)
Southern California (1508)
Special edition (11)
Spinal muscular atrophy (118)
Sponsored (13)
Startups (2002)
State (1)
Stomach cancer (4)
Supply chain (24)
Tariffs (9)
The Weekly (36)
United States (13454)
Vaccines (226)
Venture capitalists (33)
Weight loss (112)
Women's health (15)
Worklife (3)
Date
Today (83)
Last 7 days (533)
Last 30 days (1534)
Last 365 days (19864)
2025 (6365)
2024 (20914)
2023 (22801)
2022 (27289)
2021 (28412)
2020 (24006)
2019 (16835)
2018 (12188)
2017 (14069)
2016 (12171)
2015 (14702)
2014 (10594)
2013 (7646)
2012 (7685)
2011 (7793)
2010 (7547)
Location
Africa (168)
Alabama (42)
Alaska (2)
Arizona (54)
Arkansas (5)
Asia (17505)
Australia (2989)
California (3910)
Canada (1152)
China (362)
Colorado (151)
Connecticut (152)
Delaware (102)
Europe (38380)
Florida (468)
Georgia (117)
Idaho (16)
Illinois (247)
India (10)
Indiana (96)
Iowa (2)
Japan (76)
Kansas (65)
Kentucky (5)
Louisiana (3)
Maine (12)
Maryland (485)
Massachusetts (3123)
Michigan (70)
Minnesota (146)
Mississippi (1)
Missouri (26)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (993)
New Mexico (13)
New York (1056)
North Carolina (559)
North Dakota (5)
Northern California (1725)
Ohio (116)
Oklahoma (9)
Oregon (21)
Pennsylvania (745)
Puerto Rico (6)
Rhode Island (19)
South America (222)
South Carolina (4)
Southern California (1508)
Tennessee (25)
Texas (454)
Utah (54)
Virginia (79)
Washington D.C. (31)
Washington State (352)
Wisconsin (15)
274,014 Results for "context therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Context Therapeutics to Participate in Upcoming Investor Conferences - April 1, 2025
April 2, 2025
·
2 min read
Press Releases
Context Therapeutics Doses First Patient in Phase 1 Clinical Trial of CT-95
April 9, 2025
·
4 min read
Press Releases
Context Therapeutics to Participate in Upcoming Investor Conferences
February 19, 2025
·
2 min read
Press Releases
Context Therapeutics Reports Full Year 2024 Operating and Financial Results
March 20, 2025
·
7 min read
Press Releases
Context Therapeutics Presents Preclinical and Translational Data for CT-95, a Mesothelin Targeting T Cell Engager, at 2025 AACR Annual Meeting
April 30, 2025
·
4 min read
Press Releases
Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2025
March 26, 2025
·
3 min read
Press Releases
Context Therapeutics Appoints Andy Pasternak as Chairman of the Board of Directors
January 14, 2025
·
4 min read
Press Releases
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 24, 2025
February 25, 2025
·
3 min read
Business
Context Therapeutics Reports First Quarter 2024 Operating and Financial Results
Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing medicines for solid tumors, today announced its financial results for the first quarter ended March 31, 2024, and reported on recent business highlights.
May 8, 2024
·
6 min read
Press Releases
Context Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of CTIM-76
January 14, 2025
·
4 min read
1 of 27,402
Next
